HemaSphere
(Apr 2020)
Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
- John G. Gribben,
- Elisabeth de Vries,
- Nathan I. Cherny,
- Pieter Sonneveld
Affiliations
- John G. Gribben
- Elisabeth de Vries
- Nathan I. Cherny
- Pieter Sonneveld
- DOI
-
https://doi.org/10.1097/HS9.0000000000000354
- Journal volume & issue
-
Vol. 4,
no. 2
p.
e354
WeChat QR code